By james art Middleton-based Imbed Biosciences has received federal approval to sell Microlyte Ag/Lidocaine, an antimicrobial wound dressing that includes the anesthetic lidocaine to treat painful skin wounds.
The dressing uses Imbed’s synthetic matrix to deliver ionic and metallic silver along with lidocaine to treat wounds such as venous stasis ulcers, pressure ulcers, ischemic ulcers, partial thickness burns, donor site wounds, surgical wounds, post-operative incisions, abrasions and tears.
The product will be launched in May. It was approved by the Food and Drug Administration, which in 2016 approved the company’s earlier product, Microlyte Ag, for sale as a medical device. The wound-healing film was invented in 2008 by a team at UW-Madison that included Ankit Agarwal, the company’s co-founder and chief scientific officer.